Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases

2020191 citationsJournal Articlegold Open Access

Authors

Abstract

Oral and IV glutathione, glutathione precursors (N-acetyl-cysteine) and alpha lipoic acid may represent a novel treatment approach for blocking NF-κB and addressing "cytokine storm syndrome" and respiratory distress in patients with COVID-19 pneumonia.

Topics & Keywords

Long-Term Effects of COVID-19 COVID-19 Clinical Research Studies Vitamin C and Antioxidants Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Respiratory Medicine Case Reports

Volume 30, pp. 101063-101063

DOI: 10.1016/j.rmcr.2020.101063

Field-Weighted Citation Impact: 15.45